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Abstract
Background: Tracking of fatty acid (FA) contribution to plasma or serum lipids over time was shown in children and adults.
However, the potential role of FADS gene variants has not been investigated.
Methods and Principal Findings: Serum GP FA composition of 331 children aged 2 and 6 years, participating in an ongoing
birth cohort study, was analyzed. Correlation coefficients were estimated to describe FA tracking over 4 years and to assess
the influence of FADS variants on tracking. We found low to moderate tracking (r = 0.12–0.49) of FA compositions and
concentration between 2 and 6 years. Concentration changes of total monounsaturated FA and total saturated FA over time
correlated closely (r = 0.79) but percentage values were unrelated (r =20.02). Tracking for n-6 long chain polyunsaturated
fatty acid (LC-PUFA) concentrations was lower in subjects homozygous for the major allele of FADS variants and higher in
carriers of at least one minor allele, whereas for total n-3 LC-PUFA concentrations and compositions this was vice versa. For
individual n-3 PUFA inconsistent results were found.
Conclusions and Significance: Serum GP FA composition shows low to moderate tracking over 4 years with a higher
tracking for LC-PUFA metabolites than for their precursor FA. Serum PUFA levels and their tracking seem to be more
influenced by lipid and lipoprotein metabolism than by FA specific pathways.
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Introduction
Biomarkers of fatty acid (FA) status are widely used in
observational studies. They reflect a combination of dietary intake
and metabolism. Associations of FA status with current and future
health indicators have been demonstrated [1–2]. Epidemiological
and clinical studies have revealed associations between FA and
cardiovascular diseases, diabetes, and certain types of cancer
[3–5].
The concentrations of individual FA in plasma and tissues do
not evolve independently, but rather mutually influence each
other. As individual FA are preferentially partitioned into specific
lipid pools [6], the percentage FA composition of specific com-
partments is widely used to describe FA status. Although analyses
of FA status are successfully applied for the evaluation of dietary
intake [7], FA status is influenced by both diet and endogenous
metabolism. In several studies strong associations were found
between variants in the human genes fatty acid desaturase 1 (FADS1)
and fatty acid desaturase 2 (FADS2) and blood levels of polyunsat-
urated fatty acids (PUFA) [8–13]. These associations clearly
indicate an influence of endogenous metabolism on the blood
levels of essential FA. The importance of endogenous metabolism
is even greater for long chain polyunsaturated fatty acids (LC-
PUFA) than for the saturated and monounsaturated FA which can
be synthesized de novo by human metabolism [14].
FA status and in particular the balance of n-3 and n-6 LC-
PUFA have been related to long term health [15–16]. LC-PUFA
have been demonstrated in all lipid compartments considered so
far as indicative of human FA status. Their concentrations are
highest in glycerophospholipids (GP), which suggests their
suitability for describing sensitively FA status including LC-PUFA
status. Due to the differences of LC-PUFA concentrations in
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different compartments (e.g. plasma lipid fractions), analysis of
defined, purified fractions is mandatory in order to avoid
misleading results.
Another important aspect when evaluating a biomarker is
temporal variability, which depends on the turnover of the com-
partment. The composition of plasma lipids varies within days or
weeks, whereas significant changes of FA composition in adipose
tissue are only observed after months [7]. As plasma lipid com-
position may change within short periods, an investigation of the
tracking of plasma lipid FA status over years yields information on
longer term changes of dietary habits and life style factors. In
adults it has been shown that FA composition of plasma cholesteryl
esters and phospholipids showed a high degree of tracking, with
coefficients of correlation between FA percentages up to 0.83 [17–
18]. Similar values were observed in total plasma phospholipids of
a small group of Portuguese children (n = 26). However, this
observation might be very much influenced by the given cultural
and socioeconomic conditions of this particular group of children
[19].
We aimed to reevaluate the findings of Guerra et al. [19] in a
larger, population-based sample of children. Furthermore, we
aimed to investigate the influence of polymorphisms in the FADS
gene cluster on FA tracking which has not been investigated so far.
According to current knowledge, the carriers of the major alleles
of the 5 studied SNPs (rs174545, rs174546, rs174556, rs174561,
rs3834458) should have a higher conversion of LA and ALA to
their corresponding derivates than carriers of at least one minor
allele [8,11–12]. We hypothesized that carriers of the major allele
would show a greater stability of LC-PUFA values over time and
therefore show a greater degree of LC-PUFA tracking than
carriers of at least one minor allele.
Methods
Ethics statement
For this study, approval by the respective local Ethics
Committees (Bavarian General Medical Council, University of
Leipzig, Medical Council of North-Rhine-Westphalia) and written
informed consent from the families (parents) of participants were
obtained.
Study design and population
The LISA study (‘‘Influences of Lifestyle related Factors on the
Immune System and the Development of Allergies in Childhood’’)
is an ongoing population-based birth cohort study of unselected
newborns. The design of this study has been described elsewhere
before [20–21]. Between November 1997 and January 1999, 3097
healthy full-term newborns were recruited in Munich (n= 1467),
Leipzig (n = 976), Wesel (n = 306), and Bad Honnef (n = 348).
Neonates were excluded if at least one of the following exclu-
sion criteria was present: preterm birth (maturity ,37 gestational
week), low birth weight (,2500 g), congenital malformation,
symptomatic neonatal infection, antibiotic medication, hospital-
isation or intensive medical care during neonatal period. In
addition to lack of consent to participate in this study, newborns
from mothers with immune-related diseases such as autoimmune
disorders, diabetes, hepatitis B, long-term medication or abuse of
drugs and alcohol, and newborns from parents with a nationality
other than German and parents who were not born in Germany
were excluded.
We collected questionnaire data on family history of atopy,
parental education and health problems during pregnancy,
smoking of the mother during pregnancy and mothers’ exposure
to environmental tobacco smoke during pregnancy at home. The
cohort was followed up at the ages of 6, 12 and 18 months, and 2,
4, 6 and 10 years. Blood samples were collected at birth (cord
blood) and from the children at 2, 6 and 10 years.
For the present analyses, only data from the 2- and 6-year
follow-up of study center Munich (n= 1331 and n= 1172, re-
spectively) were included. Serum samples both at the age of 2 and
6 years were available for analysis in 375 children (213 boys, 162
girls). Both genotyping data and fatty acid data were available for
331 children. Figure 1 shows the origin of the samples.
Fatty acid analysis
Venous blood samples were collected in serum separator tubes
and centrifuged. Serum was frozen in plastic vials and stored at
280uC until analysis. Glycerophospholipid FA were analyzed as
described earlier [22]. Briefly, 100 ml of internal standard (1,2-
dipentadecanoyl-sn-glycero-3-phosphocholine dissolved in metha-
nol) and 0.6 ml methanol were added to 100 ml of serum, and
samples were shaken for 30 s. After centrifugation the supernatant
was transferred into another glass tube. Twenty-five ml of sodium
methoxide solution were added and tubes were shaken for
synthesis of fatty acid methyl esters (FAME). The transesterifica-
tion was stopped after 3 min by adding 75 ml methanolic HCl.
FAME were extracted twice with 300 ml hexane each. Extracts
were combined and dried under nitrogen flow at room tem-
perature. The residue was taken up in 50 ml hexane (containing
2 g/l butylated hydroxy toluene) and analyzed by gas chroma-
tography (GC).
We used GC with flame ionization detection for quantifying the
FAME. Individual FAME were identified by comparison with
authentic standards (GLC-569B, Nu-Check Prep, Inc., Elysian,
MN, USA; cis-5,8,11-eicosatrienoic acid methyl ester, Sigma-
Aldrich, Taufkirchen, Germany; methyl vaccenate (11c), methyl
octadecatetraenoate (6c, 9c, 12c, 15c) and methyl brassidate (13tr),
Larodan Fine Chemicals AB, Malmo¨, Sweden). We used the
general designations C16:1t, C18:1t, C18:2tt and C22:1t in the
results section because we cannot exclude that different isomeric
trans FA coelute.
As external standard GLC-85 (Nu-Check Prep, Inc., Elysian,
MN, USA) was used for determining the response relative to
pentadecanoic acid methyl ester (internal standard). For peak
integration EZChrom Elite version 3.1.7 (Agilent, Waldbronn,
Germany) was used.
Genotyping
Genomic DNA was extracted from EDTA blood using standard
methods and amplified by using REPLI-g UltraFast technology
(QiagenTM). Five variants of the FADS1 FADS2 gene cluster
(rs174545, rs174546, rs174556, rs174561, rs3834458) were typed,
which have been previously shown to be in strong linkage
disequilibrium with each other [8,11]. SNPs were selected based
on previous publications [8,11–12]. Applying the tagger server
program (http://www.broadinstitute.org/mpg/tagger/) in combi-
nation with HapMap we found that with the 3 SNPs rs174545,
rs174546 and rs174556 27 SNPs between basepair positions
61234329 and 61372379 of FADS1 FADS2 could be tagged. The
efficiency was 10.7 fold even though the two further SNPs
rs174561 and rs3834458 could not be included as these are not
included in the HapMap database. Genotyping of SNPs was
realized with the iPLEX (Sequenom, San Diego, CA, USA)
method by means of matrix assisted laser desorption ionization-
time of flight mass spectrometry method (MALDI-TOF MS, Mass
Array; Sequenom) according to the manufacturer’s instructions.
Standard genotyping quality control included 10% duplicate and
negative samples. Genotyping discordance rate was below 0.3%.
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Statistical analysis
For the studied subpopulation allele frequencies and Fisher’s
exact test of Hardy-Weinberg-Equilibrium were conducted with
procedure ‘‘proc allele’’ of the statistical software module SAS/
GENETICS of SAS version 9.1.3. Lewontin’s D’ and pairwise-
squared correlations r2 were calculated with the software JLIN
[23] to examine linkage disequilibrium.
FA data are presented as medians and interquartile ranges
(IQR, ranges from the 1st to the 3rd quartile), since FA with very
low concentrations showed skewed distributions.
Level of tracking between FA data obtained at the two time
points was estimated by Spearman correlation. This is the simplest
way for continuous outcome variables to asses tracking between
two measurements [24]. Furthermore, Spearman correlation
coefficients were calculated for the single SNPs applying an
additive model where homozygous minor allele carriers were
coded as 2, heterozygous coded as 1, and homozygous major allele
carriers coded as 0 ( = reference category). Spearman correlations
were performed using the statistical software PASW Statistics,
version 18.0.0.
Results
Baseline characteristics for the total study population and for the
studied subpopulation of the LISA Munich cohort are listed in
Table 1. Weight, height and BMI are comparable between the
total and the subpopulation. However, the percentage of boys,
fully breastfeeding and high maternal education is somewhat
higher and the proportion of maternal smoking during pregnancy
is slightly lower in the studied subpopulation.
Information regarding position, possible functional region,
genotyping frequencies and P-values of Fisher’s exact test for
violation of Hardy-Weinberg-Equilibrium for the five analyzed
SNPs of the FADS1 FADS2 gene cluster are given in Table 2. The
minimum P-value for any of the five analyzed SNPs was 0.69
(rs174556 and rs174561).
Lewontin’s D’ and pairwise-squared correlations r2 for the
studied subpopulation are shown in Figure 2. Lewontin’s D’
ranged between 0.97 and 1.0 and the pairwise-squared correla-
tions r2 ranged between 0.87 and 1.0, confirming that all five SNPs
are in high linkage disequilibrium.
Fatty acid composition of serum GP
Five FA, namely the saturated FA palmitic (C16:0) and stearic
acid (C18:0), the monounsaturated FA oleic acid (C18:1n-9) and
the two n-6 PUFA linoleic acid (LA, C18:2n-6) and arachidonic
acid (AA, C20:4n-6), showed the highest concentrations in serum
GP and accounted for more than 85% of total GP FA (Table S1).
Up to 45% of all serum GP FA were saturated, ,40% were
polyunsaturated, and ,15% were monounsaturated. Trans FA
were found in minor quantities, contributing less than 0.5% to
total GP FA. The abundance of n-6 PUFA was ,7 times higher
than that of n-3 PUFA in GP.
Concentrations of total saturated fatty acids (SFA), total
monounsaturated fatty acids (MUFA) and PUFA were higher at
6 years compared to 2 years, while the concentration of total trans
FA did not differ with time. Percentage values did not differ
significantly between both time points. However, the PUFA/SFA
ratio increased from 0.92 at 2 years to 0.96 at 6 years. N-6 PUFA
showed higher values at 6 years compared to 2 years, while n-3
PUFA values remained constant. The n6/n3 ratio increased from
7.5 to 8.2 over time.
Changes in concentrations of individual FA or groups of FA
were positively correlated with each other for most FA (data not
shown), e.g. changes of LA concentrations from 2 to 6 years were
highly correlated with changes of the concentrations of total SFA
(0.71***), total MUFA (0.49***), C18:3n-6 (0.30***), C20:3n-6
(0.25***), C20:4n-6 (0.41***) and C18:3n-3 (0.43***). For
Figure 1. Analyzed serum samples and genetic measurements from the Munich LISA cohort.
doi:10.1371/journal.pone.0021933.g001
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percentage values changes in LA were negatively correlated with
the changes in the percentage values of total SFA (20.50***), total
MUFA (20.40***), C20:3n-6 (20.45***), C20:4n-6 (20.34***),
C20:5n-3 (20.35***), and C22:6n-3 (20.37***). Besides the
correlation with LA, total SFA and total MUFA percentage
values were not correlated with other FA percentage values (data
not shown). The changes of total SFA concentrations over time
were highly correlated with the changes of total MUFA con-
centrations (r = 0.79***, Figure 3a), whereas no correlation was
observed between the changes of total SFA and total MUFA
percentages over the four year period (r =20.02, Figure 3b).
Tracking
For most FA the percentage contributions and concentrations
(Table S1) at the age of 2 years were significantly correlated to
those at 6 years. FA concentrations were stronger correlated
between both time points than FA percentage contributions. The
highest correlations between both time points were observed for
the n-6 LC-PUFA dihomo-gamma-linolenic acid (DGLA, C20:3n-
6), AA and docosapentaenoic acid (DPA, C22:5n-6) for both,
concentrations and percentage values.
Moderate tracking (0.6.r.0.4) was observed for the percent-
age values of four FA (C17:0, C20:3n-6, C20:4n-6, and C22:5n-6)
and for the concentrations of six FA (C17:0, C18:0, C20:3n-6,
C20:4n-6, C22:5n-6, and C22:5n-3), respectively. The majority of
all analyzed FA showed low or no tracking (r,0.4).
Concentrations of SFA in serum GP showed a higher degree of
tracking than their corresponding percentage values. Interestingly,
total SFA percentage values showed no correlation whereas single
SFA showed low to moderate tracking. For n-6 PUFA moderate
correlations between both time points were observed, with the
highest correlations for DGLA, and weaker correlations for their
precursor FA LA and gamma-linoleic acid (GLA, C18:3n-6).
Tracking of n-3 PUFA was markedly lower than that of n-6
PUFA, with lower tracking rates for the precursor n-3 PUFA
compared to their longer chain derivates. Similar findings were
observed for n-9 FA. Percentage values of mead acid (20:3n-9)
were higher correlated between both time points (r = 0.39) than
those of oleic acid (r = 0.22), a precursor of mead acid. Trans FA
and MUFA had weak correlations.
The ratio of the n-6 PUFA AA/LA showed a moderate degree
of tracking (r = 0.41), and the ratio remained practically constant
over the 4 year period with 0.4260.13 at 2 years, and 0.4060.11
at 6 years, respectively. There was an increasing trend over time
for the n-3 PUFA ratios EPA/ALA (2 years: 2.3161.27; 6 years:
2.5061.51) and DHA/ALA (2 years: 12.7268.23; 6 years:
13.5868.34). Compared to the n-6 PUFA ratio of AA/LA
somewhat lower tracking levels were observed for the n-3 PUFA
ratios EPA/ALA (r = 0.20) and DHA/ALA (r = 0.20), respectively.
Influence of FADS polymorphisms on tracking
We found that tracking of n-6 LC-PUFA concentrations (except
for C22:4n-6) was higher for homozygous and heterozygous
carriers of minor alleles in the five analyzed SNPs than for
homozygous carriers of major alleles (Table S2). In contrast,
tracking of n-6 LC-PUFA compositions showed no clear trend.
For total n-3 LC-PUFA concentrations and compositions, minor
allele carriers had a lower tracking compared to homozygous
major allele carriers but individual n-3 LC-PUFA showed no
consistent trend. Tracking of C20:3n-3 and EPA was lower in
minor allele carriers than in carriers homozygous for the major
allele, whereas results for C22:5n-3 were inconsistent. For DHA
Table 1. Baseline characteristics of the total study population and the studied subpopulation of the LISA Munich cohort.
Total population Studied subpopulation
n mean or % SD n mean or % SD
% boys 1467 52.7 331 55.6
% girls 1467 47.3 331 44.4
birth weight (kg) 1466 3.4 0.4 331 3.4 0.4
birth length (cm) 1445 52.1 2.4 326 52.0 2.3
% fully breastfed for at least 4 months 1371 68.7 329 71.4
% high maternal education 1457 63.9 328 66.5
% maternal smoking during pregnancy 1458 14.2 328 11.0
doi:10.1371/journal.pone.0021933.t001
Table 2. Characteristics of the five analyzed variants in FADS1 FADS2 gene of the studied subpopulation (n = 331).
dbSNP Position
Possible functional region
(on chromosome 11)
Alleles (major/
minor) Number (%) of subjects with genotype
P-value (Fischer’s
exact test)
bp 1/2 11 12 22
rs174545 61325882 FADS1 UTR-3 C/G 157 (47.6) 139 (42.1) 34 (10.3) 0.70
rs174546 61326406 FADS1 UTR-3 C/T 158 (47.7) 139 (42.0) 34 (10.3) 0.70
rs174556 61337211 FADS1 intron 2 C/T 166 (50.5) 138 (41.9) 25 (7.6) 0.69
rs174561 61339284 FADS1 intron 1 T/C 166 (50.5) 138 (41.9) 25 (7.6) 0.69
rs3834458 61351497 FADS2 59 flanking T/Del 154 (47.1) 142 (43.4) 31 (9.5) 0.90
Note: Del indicates deletion; SNP build 131 accessed 27 April 2010, Map to Genom Build 36.3, 11 = homozygous major, 12 = heterozygous, 22 = homozygous minor.
doi:10.1371/journal.pone.0021933.t002
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tracking was comparable between the 3 groups in all analyzed
SNPs.
Discussion
Fatty acid status
We found increasing serum GP total FA concentrations over the
4-year follow-up. The children studied had higher serum PUFA
concentrations at the age of 6 than at 2 years, whereas SFA and
MUFA concentrations showed only a slight increase over time.
Hence, the PUFA/SFA ratio increased with age. These observa-
tions point towards a change in food habits with a shift to higher
proportions of polyunsaturated dietary fat. Our findings are in
accordance with observations from Guerra et al. [19] who found
an increase of plasma phospholipid PUFA/SFA ratio in 26
Portuguese children from 2 to 5 years of age.
Plasma GP n-6 PUFA concentrations increased during the
follow-up, which likely reflects a higher intake of foods providing
LA or AA (e.g. vegetable oils, eggs, meat and meat products) at
older age [25]. In contrast, plasma concentrations of n-3 PUFA
remained almost constant over time. This is presumably attri-
butable to a low consumption of n-3 PUFA in the diets of most
German children. The main dietary sources of n-3 LC-PUFA are
fish and other seafood. Children who like to eat fish and whose
parents pay attention to a regular fish intake are likely to maintain
such habits over time, and a relatively high n-3 LC-PUFA level
will persist; whereas children who tend not to eat fish retain a low
n-3 LC-PUFA level. Our findings suggest that only few children
change their food habits with regard to fish intake over time.
The strong positive correlation between the changes in the
concentrations of total MUFA and total SFA, points towards a
strong influence of lipid metabolism on FA concentrations. This
assumption is strengthened by the absence of a correlation be-
tween changes in the percentage values of total MUFA and total
SFA, as well as previous findings of Moilanen et al. [26] who
reported a significant association between serum cholesteryl ester
FA composition and various serum lipids.
LA values seem to have a strong influence on the percentage
composition of serum GP FA, whereas the impact of SFA and
MUFA on FA composition is very low. The correlations between
the changes in FA percentages over the 4-year period indicate that
the changes in LA mainly affected SFA and MUFA. We found
negative correlations of LA with C20:3n-6, C20:4n-6, C20:5n-3
and C22:6n-3, which was in accordance with previous findings
[27].
Tracking
Tracking of FA percentage values in plasma or serum
phospholipids and cholesteryl esters has previously been reported
in children and adults [17–19,27], but tracking of FA concentra-
tions has not been investigated before. Our results revealed
tracking rates of similar magnitude compared to findings of
Guerra et al. [19] for total SFA (0.02/20.02, our results/Guerra
et al.) and total MUFA (0.22/0.25), whereas n-6 LC-PUFA
(0.35/0.63) and n-3 LC-PUFA (0.23/0.31) showed a somewhat
lower tracking in our study. This might be explained by the
different study settings. Guerra et al. examined tracking of plasma
Figure 2. Pair wise linkage disequilibrium measured by Lewontin’s D’ and r2 for the common five single nucleotide polymorphisms
(SNP) in the studied subpopulation (n=331) of the LISA Munich cohort.
doi:10.1371/journal.pone.0021933.g002
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phospholipid FA in 26 Portuguese children between the age of 2
and 5 years, whereas we examined tracking of FA in serum GP (a
subgroup of phospholipids) in a larger group of 331 German
children between the ages of 2 and 6 years. Previous publications
show that tracking of plasma cholesteryl ester FA is higher than
that of plasma phospholipid FA, and that FA tracking might be
higher in adults than in children [17–18,28]. However, indepen-
dent from the studied subjects and the analyzed lipid fraction, our
results are consistent with previously published data on FA
tracking in that n-6 LC-PUFA showed greater tracking than n-3
LC-PUFA, and that LA and ALA have a lower degree of tracking
than their LC-PUFA derivates.
We also determined tracking of FA concentrations, which
turned out to be somewhat greater than the tracking of FA
percentages, particularly for SFA. This further supports that lipid
metabolism might have a significant influence on serum GP FA
concentrations. The high tracking of C17:0, which reflects the
intake of dairy fats, might indicate a stable dietary milk and dairy
product intake. Patterson et al. [29] reported a tracking correlation
coefficient of 0.3 for dietary intakes of milk and yoghurt in Swedish
children over a period of 6 years.
Our hypothesis that carriers of the major allele show higher
tracking than carriers of at least one minor allele could be
confirmed only for serum GP total n-3 LC-PUFA levels. For
individual n-3 PUFA this trend is not consistent. In contrast to our
expectation, tracking of total n-6 LC-PUFA percentage and
concentration values was lower in subjects homozygous for the
major allele than in subjects carrying one minor allele. However,
tracking values were comparable between carriers homozygous for
the major allele and carriers homozygous for the minor allele,
except for SNP rs3834458, here tracking values of subjects homo-
zygous for the minor allele were comparable with theses of subjects
carrying one minor and one major allele.
We assume that the major portion of serum GP n-6 LC-PUFA
levels are contributed by endogenous synthesis via the desaturase/
elongase pathway, which was shown to be largely influenced by
genetic variants in the FADS1 FADS2 gene cluster [11]. Linoleic
acid, the n-6 LC-PUFA precursor, is the most abundant PUFA in
diet and serum lipids. Serum GP LA values are largely determined
by dietary intake. In our study we found an increase of LA levels
over time and only slight tracking for LA values. Thus, subjects
with higher LA conversion rates have a higher variability in n-6
Figure 3. Changes of total monounsaturated fatty acids between 2 and 6 years (delta MUFA, mg/l) show a high correlation (r =0.79)
with changes of total saturated fatty acids (delta SFA, mg/l) (a), while changes of corresponding percentage values (%) are
unrelated (b, r =20.02).
doi:10.1371/journal.pone.0021933.g003
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LC-PUFA levels depending on available LA and therefore tend to
show a lower tracking. The hypothesized association of higher
tracking with higher conversion intensity can only be observed for
very low precursor levels, as is the case for n-3 PUFA.
In conclusion, the present study documents low to moderate
tracking of serum GP FA composition over a period of 4-years.
The highest tracking was observed for n-6 LC-PUFA. Further-
more, LC-PUFA metabolites have a higher tracking than their
precursor FA. We found that FADS1 FADS2 gene variants
modulate tracking of serum GP PUFA levels. However, results
are inconsistent and the influence of general lipid and lipoprotein
metabolism seems to be more pronounced than the influence of
FA specific pathways. As a consequence FA concentrations show a
higher degree of tracking than FA percentage values.
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